BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11214128)

  • 1. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.
    Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
    Lancet; 2001 Jan; 357(9252):262-6. PubMed ID: 11214128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of colorectal cancer in relatives of patients with inflammatory bowel disease (Denmark).
    Fonager K; Sørensen HT; Mellemkjaer L; Olsen JH; Olsen J
    Cancer Causes Control; 1998 Aug; 9(4):389-92. PubMed ID: 9794170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.
    Moller FT; Andersen V; Wohlfahrt J; Jess T
    Am J Gastroenterol; 2015 Apr; 110(4):564-71. PubMed ID: 25803400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of inflammatory bowel disease in first-degree relatives with risk of colorectal cancer: A nationwide case-control study in Sweden.
    Wang K; Olén O; Emilsson L; Khalili H; Halfvarson J; Song M; Ludvigsson JF
    Int J Cancer; 2023 Jun; 152(11):2303-2313. PubMed ID: 36760205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease. An epidemiological and genetic study.
    Monsén U
    Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial occurrence of inflammatory bowel disease.
    Orholm M; Munkholm P; Langholz E; Nielsen OH; Sørensen TI; Binder V
    N Engl J Med; 1991 Jan; 324(2):84-8. PubMed ID: 1984188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.
    Riegler G; Caserta L; Castiglione F; Esposito I; Valpiani D; Annese V; Zoli G; Gionchetti P; Viscido A; Sturniolo GC; Rispo A; De Filippo FR; de Leone A; Carratu R;
    Dig Liver Dis; 2006 Jan; 38(1):18-23. PubMed ID: 16169781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distress among inflammatory bowel disease patients at high risk for colorectal cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social support.
    Rini C; Jandorf L; Valdimarsdottir H; Brown K; Itzkowitz SH
    Psychooncology; 2008 Apr; 17(4):354-62. PubMed ID: 17607717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of haematopoietic cancer in patients with inflammatory bowel disease.
    Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
    Gut; 2005 May; 54(5):617-22. PubMed ID: 15831904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
    Samadder NJ; Valentine JF; Guthery S; Singh H; Bernstein CN; Leighton JA; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Burt RW; Curtin K; Smith KR
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.